Press Releases

December 4 2013

BIO and the American Seed Trade Association (ASTA) announced today that the Data Use and...

December 3 2013

BIO issued the following statement regarding the ...

June 13 2013

The SCOTUS decision represents a departure from judicial and PTO precedent supporting...

May 2 2013

BIO shares the U.S. Trade Representative's concerns over the failings of India, China,...

April 8 2013

Strong Intellectual Property Protection Is Vital For The Life Sciences Industry.

February 11 2013

An inside look at two cases facing the Supreme Court of the United States:...

January 15 2013

BIO and the American Seed Trade Association (ASTA) are pleased with the continued support from...

June 21 2012

The Biotechnology Industry Organization (BIO) released a report on the significant...

April 18 2012

This global event for biotechnology will be held June 18-21, 2012 in Boston.

October 4 2011

Inaugural BIO China event will be held October 12-13 in Shanghai

September 8 2011

Biotechnology Industry Organization (BIO) President and CEO Jim Greenwood released the...

June 23 2011

BIO President and CEO Jim Greenwood released a statement on the passage of The Leahy-Smith...

June 21 2011

WASHINGTON, D.C. (Tuesday, June 21, 2011) - Biotechnology Industry Organization (BIO) President...

June 6 2011

The United States Supreme Court issued it's opinion on the appeal of Stanford University...

April 19 2011

BIO announces that Dr. Jörg Reinhardt, CEO of Bayer HealthCare, will provide the keynote...

April 15 2011

BIO President and CEO Jim Greenwood releases statement regarding the America Invents Act, H.R...

April 5 2011

The Biotechnology Industry Organization (BIO) hosted a U.S./China Biotechnology Examiner...

March 31 2011

BIO praises House Judiciary Committee Chairman Lamar Smith (R-TX) for his introduction of a...

March 8 2011

BIO commends the Senate for its overwhelming passage of the America Invents Act by a vote of...

February 21 2011

The Biotechnology Industry Organization (BIO) stresses the critical importance of protecting...

February 17 2011

BIO welcomes the announcement of the appointment of Teresa Stanek Rea as Deputy Director of...

February 3 2011

BIO appreciates the continued dedication of Chairman Patrick Leahy (D-VT), Ranking Member...

January 28 2011

BIO appreciates the dedication of Chairman Leahy, Ranking Member Charles Grassley (R-IA),...

June 16 2010

Landmark case instrumental in spurring the biotech revolution

March 15 2010

David Kappos, Director of the U.S. Patent and Trademark Office and Under Secretary of Commerce...

March 4 2010

BIO President and CEO Jim Greenwood released the following statement on the manager’s...

March 3 2009

Patent reform should promote innovation and improve patent quality.

July 30 2008

Small businesses that are majority-backed by venture capital, many of which are producing...

September 7 2007

Notes Strong, Bipartisan Opposition in the House, Will Continue to Work with the Senate to...

July 19 2007

Thanks chairmen for improvements made during markup.

September 20 2006

The Milken Institute study released today entitled “Mind-to-Market: A Global Analysis of...

May 30 2002

The Biotechnology Industry Organization’s (BIO) annual meeting, BIO 2002 in Toronto,...

March 3 1999

The Biotechnology Industry Organization (BIO) said today it will support Pioneer HiBred...

April 2 2014
BIO joins coalition letter to Chairman Patrick Leahy and Ranking Member Chuck Grassley expressing serious concerns with the direction of patent legislation.
February 25 2014
BIO appreciates the opportunity to participate in the Special 301 process and is hopeful that our contribution will assist the United States Trade Representative’s (USTR) efforts in preserving strong intellectual property protections for United States’ companies internationally. BIO appreciates the opportunity to comment on 2014 Special 301 Review: Identification of Countries Under Section 182 of the Trade Act of 1974: Request for Public Comment and Announcement of Public Hearing.
February 24 2014
Lila Feisee, Vice President of International Affairs testified on behalf of BIO and its 1100 members who innovate in the healthcare, agriculture, industrial, and environmental sectors. 
November 20 2013
BIO welcomes the opportunity to provide the views of its members on facilitating access to genetic resources and traditional knowledge and the sharing of benefits from their use...
October 16 2013
BIO appreciates this fourth opportunity to formally respond to the Colombian Ministry of Health’s Draft Decree on Regulatory Requirements for the Registry of Medicines of Biological Origin and we refer you to our previous comments filed to the Colombian Ministry of Health on April 24th 2012, June 12th 2012 and February 21st 2013 for background about BIO and its interest in this Decree. 
February 26 2014
Transparent communication important for Patients and Physicians
December 4 2013
BIO and the American Seed Trade Association (ASTA) announced today that the Data Use and Compensation Agreement (DUCA) is open for signature. 
December 3 2013
BIO issued the following statement regarding the Innovation Act (H.R. 3309), as reported by the House Judiciary Committee.
June 13 2013
The SCOTUS decision represents a departure from judicial and PTO precedent supporting patentability of DNA molecules. The decision could create business uncertainty for a range of inventions.
May 2 2013
BIO shares the U.S. Trade Representative's concerns over the failings of India, China, Brazil and Canada to provide adequate IP protection for biotechnology companies creating novel and innovative products.